Accounting for our 64% drug release efficiency and assuming uniform drug distribution within the tumor, this treatment strategy is predicted to produce a LUM concentration of 87 μM in the tumor (equivalent to 87 nmol/g tumor), considerably exceeding the IC50 of LUM in either H520 or H460 cell lines. This evidence concerns the gene LUM and neoplasm.